AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUNIC, INC. Director's Dealing 2014

Oct 9, 2014

10196_dirs_2014-10-09_6eaa4077-389e-43e4-9f33-e3f3d0dd1756.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2014-10-08

Reporting Person: Nash Duane (See Remarks)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-08	Common Stock	P	100	$17.50	Acquired	9324	Direct

Footnotes

F1: Includes 9,224 shares that were incorrectly reported as held indirectly in the Form 3 filed April 16, 2014. These shares should have been reported as held directly by the Reporting Person.